Live feed07:30:00·6mPRReleasevia QuantisnowAbeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)ByQuantisnow·Wall Street's wire, on your screen.ABEO· Abeona Therapeutics Inc.Health Care
